Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

TGI / Triumph Group, Inc. - Stock Institutional Ownership and Shareholders -

Triumph Group, Inc. (NYSE:TGI) has 300 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52,679,018 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, Price T Rowe Associates Inc /md/, Dimensional Fund Advisors Lp, State Street Corp, Lsv Asset Management, Teachers Advisors Inc, Re Advisers Corp, Towle & Co, and Connor, Clark & Lunn Investment Management Ltd. (44-0)

The Zacks Analyst Blog Highlights: Lockheed Martin, Boeing, Textron, Triumph and Harris

2018-02-09 zacks
Chicago, IL – February 9, 2018 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Lockheed Martin Corp. (LMT - Free Report) , The Boeing Company (BA - Free Report) , Textron Inc. (TXT - Free Report) , Triumph Group (TGI - Free Report) and Harris Corp. (63-0)

Defense Stock Roundup: BA, HRS Top Q4 Earnings, Wall Street Takes a Hit

2018-02-08 zacks
The Q4 earnings season has crossed the halfway mark, with more than 75% of S&P 500’s total market capitalization having released their quarterly results. As of Feb 7, of the 294 index members that have reported results, 79.6% beat on earnings, while 76.9% surpassed revenue estimates. (82-0)

Investors Haven't Caught On Yet To Triumph Group's Turnaround

2018-02-05 seekingalpha
Triumph Group under new management has made costly adjustments in order to restore credibility with customers and stop revenue declines. (8-0)

ABIOMED (ABMD) Beats Earnings and Revenue Estimates in Q3

2018-02-02 zacks
ABIOMED Inc. (ABMD - Free Report) reported third-quarter fiscal 2018 adjusted earnings of 70 cents per share, easily beating the Zacks Consensus Estimate of 50 cents. Moreover, adjusted earnings per share grew a whopping 105.9% on a year-over-year basis. (35-0)

Sony (SNE) Reports Q3 Results, Earnings & Revenues Up Y/Y

2018-02-02 zacks
Sony Corporation (SNE - Free Report) reported third-quarter fiscal 2017 earnings per share of ¥228.91 ($2.03), which grew a colossal 1402% from the year-ago quarter figure of ¥15.24, on the back of robust revenue growth. (38-0)

Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q4

2018-02-02 zacks
Omnicell, Inc. (OMCL - Free Report) reported adjusted earnings (excluding the one-time tax benefit from the tax reform) per share of 54 cents in fourth-quarter 2017, beating the Zacks Consensus Estimate by a couple of cents. The figure is at the high end of the guided range of 49-55 cents. (17-0)

Teva Completes Sale of Women's Health Segment for $703M

2018-02-02 zacks
Teva Pharmaceutical Industries Ltd. (TEVA - Free Report) announced that it has completed the divestment of its global women’s health business to privately-held private equity firm, CVC Capital Partners. The deal was closed for $703 million in cash. (212-0)

What's in the Offing for Microchip (MCHP) in Q3 Earnings?

2018-02-02 zacks
Microchip Technology Inc. (MCHP - Free Report) is set to release fiscal third-quarter 2018 earnings on Feb 6. We note that the company has delivered positive earnings surprise in each of the trailing four quarters with an average surprise of 9.26%. (138-0)

Essex Property (ESS) to Post Q4 Earnings: What's in Store?

2018-02-02 zacks
Essex Property Trust, Inc. (ESS - Free Report) is scheduled to report fourth-quarter 2017 results on Feb 7, after the market closes. The company’s funds from operations (FFO) per share and revenues are anticipated to increase year over year. In the prior quarter, this San Mateo, CA-based residential real estate investment trust (REIT) generated a positive surprise of 0.68% in terms of FFO per share. (14-0)

Amazon (AMZN) Q4 Earnings Beat, Sales Up on AWS Strength

2018-02-02 zacks (AMZN - Free Report) reported fourth-quarter 2017 earnings of $3.75 per share, which soared 143.3% year over year. Adjusting for a tax benefit of almost $789 million due to the recent enactment of the U.S. Tax Cuts and Jobs Act of 2017, earnings of $2.16 beat the Zacks Consensus Estimate of $1.85. Net sales of $60.45 billion comfortably surpassed the Zacks Consensus Estimate of $59.98 billion. (241-0)

Chevron (CVX) Q4 Earnings Jump, Helped by Rising Oil Price

2018-02-02 zacks
U.S. energy giant Chevron Corp. (CVX - Free Report) reported weaker-than-expected fourth-quarter earnings after excluding the impacts of U.S. tax reform. The company reported adjusted earnings per share of 73 cents, lower than the Zacks Consensus Estimate of $1.27. (34-0)

Charter Communications' (CHTR) Q4 Earnings Top Estimates

2018-02-02 zacks
Charter Communications Inc. (CHTR - Free Report) reported impressive financial results for fourth-quarter 2017, wherein both the top and the bottom line outpaced the Zacks Consensus Estimate. GAAP net income in the reported quarter was $9,553 million or $34.56 per share compared with net income of $454 million or $1.67 in the year-ago quarter. However, adjusted earnings per share of 86 cents were a penny above the Zacks Consensus Estimate. (126-0)

Aon's (AON) Q4 Earnings Surpass Expectations, Improve Y/Y

2018-02-02 zacks
Aon plc’s (AON - Free Report) fourth-quarter 2017 adjusted operating earnings of $2.35 surpassed the Zacks Consensus Estimate by 0.4%. The bottom line also increased 18% from the year-ago quarter. (22-0)

Merck (MRK) Beats on Q4 Earnings, Lags Sales, Guides for '18

2018-02-02 zacks
Merck & Co., Inc. (MRK - Free Report) reported fourth-quarter 2017 adjusted earnings of 98 cents per share, which beat the Zacks Consensus Estimate of 94 cents by 4.3%. Earnings rose 10.1% year over year as slightly higher sales, lower taxes and higher other income made up for higher R&D costs in the quarter. (18-0)

CUSIP: 896818101